Conception Bio

Conception Bio is a biotech company in Berkeley, United States, founded in 2018. It has raised $38.0M across 3 rounds, most recently an $8.0M Venture Round in 2024 (est.).

Advancing the future of fertility.

Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$38.0M
Last Round
$8.0M Venture RoundJan 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds for this company. The full record is or through the API.

About

Conception is a Berkeley-based biotechnology company developing in-vitro gametogenesis (IVG) technology to generate functional human egg cells from induced pluripotent stem cells (iPSCs). The company combines stem cell biology, 3D ovarian organoid engineering, and computational genomics to recreate the key developmental stages from iPS cells through primordial germ cells to mature eggs. High-throughput genetic screens and computer vision-based quality scoring enable rapid iteration across differentiation conditions. Conception's goal is to make biological parenthood possible for people facing age-related fertility decline or medical barriers, subject to future regulatory approval.

Summary

It lists 11–50 employees. It has raised $38.0M in total across 3 rounds, most recently a $8.0M Venture Round in 2024 (est.).

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture Round2024 (est.)
$8.0M

Sign up to see all 3 events

Funding: Seed through Venture Round. Amounts, valuations, and investors where available.

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Conception Bio on Indexed.vc
<a href="https://indexed.vc/companies/conception-bio"><img src="https://indexed.vc/api/badge/company/conception-bio" alt="Conception Bio on Indexed.vc" width="260" height="76" /></a>